Stagnating sales and delayed rights issue adds to Zoono’s woes

Stagnating sales and delayed rights issue adds to Zoono’s woes
Zoono did it tough after covid induced boom. (Image: Getty)
Denise McNabb
A mounting stockpile of unsold product with looming expiry dates and the postponement of a non-renounceable rights issue due to undisclosed “external circumstances” are the latest woes for cash-strapped Australian securities exchange-listed New Zealand hand and sanitiser manufacturer Zoono Group.In its second quarterly report to December 2023, released Wednesday, the company acknowledged significant work needed to be done before it was cashflow positive and profitable.The group reported a $514,000 net cash deficit on operating activ...

More Markets

The ‘Aussie Premium’ baked into NZX stocks
Opinion

Brian Robins: The ‘Aussie Premium’ baked into NZX stocks

New Zealand entities launching in Australia have clear benefits.

An updated recap: Fonterra’s $4.2b Mainland sale
Primary Sector

An updated recap: Fonterra’s $4.2b Mainland sale

Today's the day the sale will get the blessing of farmers.

Locate Technologies posts quarterly loss ahead of NZX listing move
Markets

Locate Technologies posts quarterly loss ahead of NZX listing move

Locate will be providing New Zealand’s first listed bitcoin treasury.